Coronary Disease Surveillance in the Community: Angiography and Revascularization.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
07 04 2020
Historique:
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 9 3 2021
Statut: ppublish

Résumé

Background Temporal declines in cardiac stress tests results, coronary revascularization, and cardiovascular mortality have suggested a decline in the population burden of coronary disease until the 2000s. However, recent data indicate these favorable trends could be ending. We aimed to assess the evolution of the population burden of coronary disease in the community by examining trends in angiography and revascularization. Methods and Results We analyzed age- and sex-adjusted trends from all coronary angiographic diagnostic procedures and revascularizations performed in Olmsted County, MN from 2000 to 2018. A total of 12 981 invasive angiograms were performed among 9049 individuals (64% men; 55% aged ≥65 years). Adjusted angiography rates decreased by 30% (95% CI, 25%-34%) between 2000 and 2009 and leveled off thereafter. Including computed tomography, angiography uncovered an increase in angiography use in recent years (risk ratio=1.15 [95% CI, 1.07-1.23] for 2018 versus 2014) and a decline in the prevalence of anatomic CAD from 2000 to 2018. CAD severity declined substantially from 2000 to 2009, followed by a plateau. Among 6570 revascularizations (72% men; 57% aged ≥65 years), 77% were percutaneous coronary interventions and 23% coronary artery bypass graft surgeries. The adjusted revascularization rates declined by 34% (95% CI, 27%-39%) from 2000 to 2009, followed by a plateau (risk ratio=1.10 [95% CI, 1.00-1.22]). Conclusions Between 2000 and 2018 in the community, coronary angiography use declined initially, leveled off, and then increased. Trends in CAD severity and revascularization use decreased then plateaued. The most recent trends are concerning as they suggest the burden of coronary disease is no longer declining. This warrants reinvigorated primary prevention and population surveillance.

Identifiants

pubmed: 32237975
doi: 10.1161/JAHA.119.015231
pmc: PMC7428619
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015231

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL120957
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

J Am Coll Cardiol. 2012 May 29;59(22):1995-2027
pubmed: 22578925
MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1227-32
pubmed: 19910909
Mayo Clin Proc. 1996 Mar;71(3):266-74
pubmed: 8594285
J Am Heart Assoc. 2020 Apr 7;9(7):e015231
pubmed: 32237975
Am Heart J. 2007 Apr;153(4):594-605
pubmed: 17383299
J Am Coll Cardiol. 2007 Sep 25;50(13):1223-9
pubmed: 17888838
Int J Epidemiol. 2012 Dec;41(6):1614-24
pubmed: 23159830
Am Heart J. 2012 Oct;164(4):547-552.e1
pubmed: 23067913
Int J Cardiol. 2015 Mar 15;183:6-10
pubmed: 25662046
Circulation. 2006 Jan 24;113(3):374-9
pubmed: 16432068
JAMA Cardiol. 2016 Aug 1;1(5):594-9
pubmed: 27438477
Circulation. 2007 Jan 2;115(1):127-55
pubmed: 17179025
N Engl J Med. 2007 Jun 7;356(23):2388-98
pubmed: 17554120
Circulation. 2010 Feb 23;121(7):863-9
pubmed: 20142444
JAMA. 2011 May 4;305(17):1769-76
pubmed: 21540420
JAMA Intern Med. 2015 Mar;175(3):454-6
pubmed: 25559059
JAMA. 2009 Nov 18;302(19):2104-10
pubmed: 19920234
Mayo Clin Proc. 2015 May;90(5):597-605
pubmed: 25794453
Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):193-7
pubmed: 21304092
JAMA Cardiol. 2019 Mar 1;4(3):203-205
pubmed: 30810699
Am Heart J. 2011 Nov;162(5):932-7
pubmed: 22093211
Am J Med. 2015 Feb;128(2):144-51
pubmed: 25261010
JAMA Intern Med. 2014 Oct;174(10):1630-9
pubmed: 25156821
Circulation. 2012 Apr 17;125(15):1848-57
pubmed: 22420957
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
N Engl J Med. 2010 Jun 10;362(23):2155-65
pubmed: 20558366
JAMA. 2010 May 26;303(20):2043-50
pubmed: 20501926
J Am Coll Cardiol. 2010 Nov 23;56(22):1864-94
pubmed: 21087721
Annu Rev Med. 2002;53:409-35
pubmed: 11818483
Mayo Clin Proc. 2020 Feb;95(2):319-327
pubmed: 31759674
J Am Coll Cardiol. 2009 Feb 10;53(6):530-53
pubmed: 19195618
Mayo Clin Proc. 2012 Feb;87(2):151-60
pubmed: 22305027
Circulation. 2015 Jan 27;131(4):362-70; discussion 370
pubmed: 25533970
Circ Cardiovasc Imaging. 2017 Jul;10(7):
pubmed: 28687538
Circulation. 2006 May 16;113(19):2285-92
pubmed: 16682616
JAMA. 2015 Nov 17;314(19):2045-53
pubmed: 26551163
JAMA. 2012 May 2;307(17):1801-2
pubmed: 22492759
BMC Cardiovasc Disord. 2017 Jul 18;17(1):192
pubmed: 28720073

Auteurs

Yariv Gerber (Y)

Department of Health Sciences Research Mayo Clinic Rochester MN.
Department of Epidemiology and Preventive Medicine School of Public Health Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel.

Raymond J Gibbons (RJ)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Susan A Weston (SA)

Department of Health Sciences Research Mayo Clinic Rochester MN.

Matteo Fabbri (M)

Department of Health Sciences Research Mayo Clinic Rochester MN.

Joerg Herrmann (J)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Sheila M Manemann (SM)

Department of Health Sciences Research Mayo Clinic Rochester MN.

Robert L Frye (RL)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Rabea Asleh (R)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Kevin Greason (K)

Department of Cardiovascular Surgery Mayo Clinic Rochester MN.

Jill M Killian (JM)

Department of Health Sciences Research Mayo Clinic Rochester MN.

Véronique L Roger (VL)

Department of Health Sciences Research Mayo Clinic Rochester MN.
Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH